Clinical Trials Browser

Phase 2 × OTHER × telapristone acetate × Clear all

NCT02314156 2023-02-22

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Phase 2 Completed

67 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01800422 2020-01-18

Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer

Phase 2 Unknown

Breast Neoplasms